MCAG · XBRL financial data

Mountain Crest Acquisition Corp. V financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (MCAG's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
General and administrative	1,989	126*	84	145	202	187*	191	120	77	84*	120	101
Operating income (loss)	(1,989)	(126)*	(84)	(145)	(202)	(187)*	(191)	(120)	(77)	(84)*	(120)	(101)
Interest income	24*	0*	—	—	—	year only	—	—	—	year only	—	—
Interest expense	2	1*	1	0	0*	0*	—	—	—	—	—	—
Income tax expense (benefit)	14	15*	14	20	5	6*	2	2	2	2*	1	1
Net income (loss)	(1,933)	(69)*	(26)	(65)	(131)	(153)*	(181)	(111)	(66)	(73)*	(114)	5

Fiscal quarters (MCAG's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	11	16	24	21	46	117	28	25	41	12	97	18
Total current assets	—	16	128	94	80	157	43	88	78	33	139	34
Total assets	5,517	5,629	5,867	5,959	6,074	1,314	1,212	1,270	1,272	874	987	890
Total current liabilities	—	1,277	1,541	1,097	1,343	1,521	1,600	1,768	1,837	1,652	1,879	1,778
Total liabilities	3,166	3,347	3,611	3,167	3,413	3,591	3,670	3,838	3,907	3,722	3,949	3,848
Accumulated deficit	(5,175)	(5,244)	(5,270)	(5,334)	(5,465)	(5,666)	(5,847)	(5,958)	(6,024)	(5,903)	(6,017)	(6,012)
Total stockholders' equity	(3,124)	(3,297)	(3,428)	(2,995)	(3,195)	(3,440)	(3,625)	(3,735)	(3,803)	(3,684)	(3,802)	(3,800)
Total liabilities and equity	5,517	5,629	5,867	5,959	6,074	1,314	1,212	1,270	1,272	874	987	890
Common shares outstanding (cover page) thousands of shares	3,170	3,094	3,320	3,320	2,902	2,902	2,902	2,902	2,873	2,873	2,873	2,873

Fiscal quarters (MCAG's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	(1,933)	(69)*	(26)	(65)	(131)	(153)*	(181)	(111)	(66)	(73)*	(114)	5
Net cash from operating activities	(109)*	(93)*	(130)	(358)*	(123)*	(310)*	(89)	(233)*	(134)*	(287)*	(165)	(79)*
Net cash from investing activities	125*	(52)*	(52)	(52)*	(52)*	4,877*	—	—	—	year only	—	—
Net cash from financing activities	(101)*	150*	190	407*	200*	(4,497)*	—	—	150*	(106)*	250	0*

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Mountain Crest Acquisition Corp. V	18	not reported	(79)*	2.9M	0.2 quarters	Q2 FY26 10-QJun 30, 2026
Co-Diagnostics	3,650	166	(7,153)*	6.3M	0.5 quarters	Q2 FY26 10-QJun 30, 2026
Lifeward	9,448	6,623	(6,005)*	2.8M	1.6 quarters	Q2 FY26 10-QJun 30, 2026
Guided Therapeutics	12	0	(319)*	96.5M	0.0 quarters	Q2 FY26 10-QJun 30, 2026
Nexgel	1,706	3,686	(2,197)*	9.7M	0.8 quarters	Q2 FY26 10-QJun 30, 2026
Lyra Therapeutics	15,893	7*	(6,066)*	1.8M	2.6 quarters	Q4 FY25 10-KDec 31, 2025
Medinotec	2,584	3,201	108*	11.8M	—	Q2 FY27 10-QAug 31, 2026
Intelligent Bio Solutions	3,992	1,146*	(3,182)*	3.0M	1.3 quarters	Q4 FY26 10-KJun 30, 2026
PAVmed	3,784	33	(2,663)*	8.0M	1.4 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.